Xiaoling Liu

456 citations
24 papers · 369 indexed · h-index 12
Topics
Autophagy in Disease and Therapy (4 papers)Hippo pathway signaling and YAP/TAZ (4 papers)Protease and Inhibitor Mechanisms (3 papers)
Partner nations
ChinaJapanUnited States

In The Last Decade

Xiaoling Liu

24 papers receiving 367 citations

Peers

Xiaoling Liu
Comparison fields: 5 of 76
  • Molecular Biology 176
  • Cell Biology 66
  • Surgery 62
  • Epidemiology 57
  • Immunology 44
Replace Rossana Tiberio with:
Rossana Tiberio Italy
Marie‐Sophie Narzt Austria
Michael T. Sturniolo United States
Shou-Ching Jaminet United States
Shingo Tajima Japan
A Rum Kim South Korea
Seunghyun Bang South Korea
Kyungjong Kim South Korea
Zhehu Jin China
Xiaoling Liu relative to Rossana Tiberio Italy Rossana Tiberio's profile →
Citations per field
00.5×4.4×
Rossana Tiberio · 1×
Citations per year

Countries citing papers authored by Xiaoling Liu

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Liu more than expected).

Fields of papers citing papers by Xiaoling Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Liu. The network helps show where Xiaoling Liu may publish in the future.

Co-authorship network of co-authors of Xiaoling Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Liu. A scholar is included among the top collaborators of Xiaoling Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Liu. Xiaoling Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 14
3 5
4 10
5 3
6 8
7 6
8 50
9 21
10 17
11 21
12 44
13 18
14 5
15 21
16 17
17 14
18 9
19 18
20 40

About Xiaoling Liu

Xiaoling Liu is a scholar working on Immunology and Allergy, Cell Biology and Cancer Research, having authored 24 papers that have together received 369 indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (4 papers), Hippo pathway signaling and YAP/TAZ (4 papers) and Protease and Inhibitor Mechanisms (3 papers). The work is most often cited by research in Cell Biology (66 citations), Immunology and Allergy (24 citations) and Rehabilitation (23 citations). Xiaoling Liu has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Takashi Ikejima, Shunji Hattori, Toshihiko Hayashi, Hitomi Fujisaki, Shin‐ichi Tashiro, Kazunori Mizuno, Masayuki Yamato, Satoshi Onodera, Yeli Zhao and Qian Xu. Their work appears in journals such as Journal of Agricultural and Food Chemistry, Food Chemistry and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026